Supplementary Figure 6 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors
Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres
0 citations
Miguel Soares
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
11Publications signalées
1Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Fibroblast Growth Factor ResearchEosinophilic Disorders and SyndromesIgG4-Related and Inflammatory DiseasesGastrointestinal Tumor Research and TreatmentLung Cancer Treatments and Mutations
Publications récentes
Supplementary Figure S1 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors
Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres
0 citations
Supplementary Figure S2 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors
Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres
0 citations
Supplementary Figure S5 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors
Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres
0 citations
Supplementary Figure S4 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors
Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres
0 citations
Supplementary Table S1 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors
Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres
0 citations
Supplementary Figure S3 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors
Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres
0 citations
Supplementary Table S3 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors
Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres
0 citations
Supplementary Table S2 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors
Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres
0 citations
Data from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors
Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres
0 citations
Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2 -Driven Tumors
F. Facchinetti, Antoine Hollebecque, Rémy Barbé, Dong Man Jang et autres
1 citationClinical Cancer Research
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.